Coriell Life Sciences, Inc. — Form D
Coriell Life Sciences, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2016-07-19. The offering totals $1.5M, of which $605K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-07-19
- Form: D
- Accession: 0001675480-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $605K
- Remaining: $895K
- Investors: 9
- Date of first sale: 2016-06-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-267302
Issuer
- Name: Coriell Life Sciences, Inc.
- CIK: 0001675480
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 4747 SOUTH BROAD STREET, PHILADELPHIA, PA, 19112
- Phone: 888.415.7834
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Stephen F Andriole | Director | Camden, NJ |
| Michael F Christman | Director | Camden, NJ |
| Scott Megill | Director | Philadelphia, PA |
| Scott Megill | Executive Officer | Philadelphia, PA |
| Dr. Stephen Andriole | Director | Philadelphia, PA |
| Peter Driscoll | Director | Philadelphia, PA |
Other filings by this issuer (1)
More